Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor, Subjects”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01009073
What this trial is testing

A Study Evaluating ABT-263 With Erlotinib, ABT-263 With Irinotecan, and ABT-263 Monotherapy in Cancer Subjects

Who this might be right for
Solid Tumors
AbbVie (prior sponsor, Abbott) 51
Early research (Phase 1)Study completedNCT07635173
What this trial is testing

SM-1 Combined With Temozolomide in Subjects With Refractory or Recurrent High-Grade Gliomas

Who this might be right for
GliomaGlioblastomas (GBM)High Grade Gliomas
Shenzhen Zhenxing Medical Technology Co., Ltd 35
Testing effectiveness (Phase 2)Study completedNCT02077166
What this trial is testing

Ibrutinib in Combination With Lenalidomide and Rituximab in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Relapsed Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma
Pharmacyclics LLC. 138
Testing effectiveness (Phase 2)Ended earlyNCT05075577
What this trial is testing

EPI-7386 in Combination with Enzalutamide Compared with Enzalutamide Alone in Subjects with MCRPC

Who this might be right for
Prostate Cancer
ESSA Pharmaceuticals 77
Testing effectiveness (Phase 2)Ended earlyNCT04267120
What this trial is testing

Lenvatinib (LEN) in Combination With Pembrolizumab (KEYtruda) in Subjects With Locally Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma (The LENKYN Trial)

Who this might be right for
Renal Cell Carcinoma
Washington University School of Medicine 11
Testing effectiveness (Phase 2)Ended earlyNCT02201524
What this trial is testing

Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

Who this might be right for
Plaque Psoriasis
Pfizer 59
Large-scale testing (Phase 3)Study completedNCT02393859
What this trial is testing

Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Leukemia, Acute Lymphoblastic
Amgen 111
Not applicableActive Not RecruitingNCT04905069
What this trial is testing

Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer

Who this might be right for
Prostate Cancer
Boston Scientific Corporation 500
Early research (Phase 1)Study completedNCT05740202
What this trial is testing

A Trial of SHR-7367 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Shanghai Hengrui Pharmaceutical Co., Ltd. 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT04404595
What this trial is testing

Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers

Who this might be right for
Gastric CancerPancreatic Cancer
CARsgen Therapeutics Co., Ltd. 110
Large-scale testing (Phase 3)Study completedNCT04914195
What this trial is testing

Leuprolide Acetate 3.75 mg Depot Injection for Patients With Advanced Prostate Cancer

Who this might be right for
Advanced Prostate Adenocarcinoma
Bharat Serums and Vaccines Limited 155
Not applicableLooking for participantsNCT04095195
What this trial is testing

Registry of Subjects at Risk of Pancreatic Cancer

Who this might be right for
Familial Pancreatic CancerBRCA1 MutationBRCA2 Mutation+4 more
Associazione Italiana per lo Studio del Pancreas 1,000
Early research (Phase 1)Study completedNCT06126575
What this trial is testing

A PK Study Testing Single Oral Dose of Elacestrant in Subjects With Normal or Severely Impaired Hepatic Function

Who this might be right for
Hepatic Impairment
Stemline Therapeutics, Inc. 16
Early research (Phase 1)Study completedNCT03641586
What this trial is testing

The Study of BGB-283 in Chinese Subjects With Local Advanced or Metastatic Malignant Solid Tumor

Who this might be right for
Solid Tumors
BeiGene 42
Early research (Phase 1)UnknownNCT05781386
What this trial is testing

A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors

Who this might be right for
Advanced Solid TumorCutaneous T Cell Lymphoma
Jiangsu Simcere Biologics Co., Ltd 255
Early research (Phase 1)Study completedNCT03260322
What this trial is testing

A Multiple-dose Study of ASP8374, an Immune Checkpoint Inhibitor, as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Global Development, Inc. 169
Testing effectiveness (Phase 2)Ended earlyNCT01353222
What this trial is testing

DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
Dendreon 142
Large-scale testing (Phase 3)Study completedNCT03691831
What this trial is testing

A-101 Topical Solution for the Treatment of Common Warts

Who this might be right for
Common Wart
Aclaris Therapeutics, Inc. 502
Early research (Phase 1)Active Not RecruitingNCT03860272
What this trial is testing

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

Who this might be right for
Advanced CancerAngiosarcomaColorectal Cancer Without Liver Metastases+5 more
Agenus Inc. 499
Early research (Phase 1)Active Not RecruitingNCT04648202
What this trial is testing

FS120 Phase 1/1b Study in Patients With Advanced Malignancies

Who this might be right for
Advanced CancerMetastatic Cancer
invoX Pharma Limited 82
Next Page